Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies

Lance Alstodt, CEO of BioRestorative Therapies BRTX, was recently a guest on Benzinga's All-Access. 

BioRestorative Therapies is a regenerative medicine company that wants to alleviate chronic lower back pain, obesity and diabetes and is developing stem cell therapies to meet that end. The company's flagship program, BRTX-100, which is in a phase 2 clinical trial, uses a patient's stem cells to alleviate chronic back pain. Meanwhile, ThermoStem®  uses adipose-derived (brown fat) stem cells to generate new brown fat tissue to target metabolic diseases, including obesity and type 2 diabetes. Both are addressing unmet health needs that inflict pain and suffering on millions of people around the world. 

Watch the full interview here: 

Featured image by Joyce Hankins on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.